TY  - GEN
AU  - Yoon,Hong In
AU  - Koom,Woong Sub
AU  - Kim,Yong Bae
AU  - Min,Byung Soh
AU  - Lee,Kang Young
AU  - Kim,Nam Kyu
AU  - Shin,Sang Joon
AU  - Ahn,Joong Bae
AU  - Keum,Ki Chang
TI  - Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkers
SN  - 1432-1335
PY  - 2014///0411
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - blood
KW  - Carcinoembryonic Antigen
KW  - Chemoradiotherapy, Adjuvant
KW  - adverse effects
KW  - Enzyme-Linked Immunosorbent Assay
KW  - ErbB Receptors
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - methods
KW  - Neoplasm Staging
KW  - Predictive Value of Tests
KW  - Prospective Studies
KW  - Receptors, Urokinase Plasminogen Activator
KW  - Rectal Neoplasms
KW  - Tissue Inhibitor of Metalloproteinase-1
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00432-013-1578-y
ER  -